Wo Vision zur Struktur wird:
Ein durchgängig integriertes System

From Swiss genetics to clinical care in Dresden: Our professional societies work hand in hand to transform scientific potential into reliable, high-quality care.

The source of innovation

Scientific excellence – together with partners from Switzerland.

Innuana AG

Research platform & translation

The bridge to international science. Innuana translates preclinical data into clinical protocols and defines the scientific benchmarks for our global laboratory network.

Grow Art AG

Focus: genetics & process expertise.

Quality starts with genetics. Grow Art AG develops proprietary strains and safeguards process know‑how for reproducible raw‑material quality at the highest level.

The strategic nucleus

The foundation for growth and stability.

 

Medi First Invest GmbH

Strategic management & investment
The architectural core of the group. Invest manages the strategic capital allocation, secures the investment portfolio, and develops the systemically important infrastructure (real estate) for our locations.

Scientific refinement

Pharmazeutische Präzision „Made in Germany“

MediFirst R&D GmbH

Drug research & evidence

Evidence as the foundation. R&D designs and manages clinical trials to validate our care and development approaches according to the highest scientific standards.

MediFirst Biotech GmbH

Manufacturing & pharmaceutical wholesaling

Technological superiority. Biotech develops innovative extraction methods and advanced delivery systems to specifically improve the bioavailability of our active ingredients.

MediFirst Pharma GmbH

Manufacturing & pharmaceutical wholesaling

The certified gatekeeper. As the marketing authorization/placing-on-the-market entity (§ 52a AMG), Pharma is responsible for import, GMP batch release and seamless compliance

Societal impact

Where the principle becomes quality of life.

MediFirst Medicum (Dresden)

Care & Structured Evidence Processes

The clinical spearhead. At Medicum, interdisciplinary care approaches are implemented. Here, we generate essential real-world evidence data that flows directly back into our research. The evidence processes are conducted in compliance with GDPR, are purpose-bound, and are supported by governance.

MediFirst NPO

Education & advocacy.

Knowledge creates acceptance. The NPO provides education, promotes political dialogue, and reduces prejudice against modern cannabinoid therapies.

The operational backbone

Infrastructure for safe care delivery.

MediFirst Supply GmbH

Medical technology & materials

Infrastructural security. Supply ensures the physical availability of high technology (e.g., low‑dose X‑ray) and specialized requirements for the entire care network.

MediFirst Commerce GmbH

B2B sales & training.

The interface to the market. Commerce steers strategic sales, concludes offtake agreements and trains professionals in handling our therapies.